D. Romashko

A mouse model of Rubinstein-Taybi syndrome: Defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4

T. Tully, Regina Lidge, R. Bourtchouladze, 2003, Proceedings of the National Academy of Sciences of the United States of America.

EGFR Oncogenes Expressed In Glioblastoma Are Activated As Covalent Dimers And Paradoxically Stimulated By Erlotinib

A. Flohr, A. Mayweg, N. Ishiyama, 2019, bioRxiv.

Reversible Linkage of Two Distinct Small Molecule Inhibitors of Myc Generates a Dimeric Inhibitor with Improved Potency That Is Active in Myc Over-Expressing Cancer Cell Lines

F. Barany, Jutta Wanner, D. Werner, 2015, PloS one.

Discovery and optimization of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1.

James G. Tarrant, M. Albertella, D. Berger, 2013, Bioorganic & medicinal chemistry letters.

Discovery of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1: optimization of kinase selectivity and pharmacokinetics.

M. Albertella, E. May, D. Romashko, 2013, Bioorganic & medicinal chemistry letters.

Computational and Functional Analyses of HER2 Mutations Reveal Allosteric Activation Mechanisms and Altered Pharmacologic Effects

G. Frampton, J. Hopkins, N. Ishiyama, 2022, Cancer research.